首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5280篇
  免费   341篇
  国内免费   23篇
耳鼻咽喉   85篇
儿科学   84篇
妇产科学   106篇
基础医学   812篇
口腔科学   509篇
临床医学   367篇
内科学   1130篇
皮肤病学   167篇
神经病学   385篇
特种医学   141篇
外科学   544篇
综合类   21篇
一般理论   2篇
预防医学   513篇
眼科学   146篇
药学   371篇
中国医学   32篇
肿瘤学   229篇
  2024年   7篇
  2023年   52篇
  2022年   59篇
  2021年   153篇
  2020年   82篇
  2019年   121篇
  2018年   267篇
  2017年   184篇
  2016年   219篇
  2015年   244篇
  2014年   235篇
  2013年   356篇
  2012年   510篇
  2011年   499篇
  2010年   236篇
  2009年   158篇
  2008年   319篇
  2007年   300篇
  2006年   294篇
  2005年   258篇
  2004年   230篇
  2003年   195篇
  2002年   130篇
  2001年   78篇
  2000年   95篇
  1999年   67篇
  1998年   24篇
  1997年   8篇
  1996年   9篇
  1995年   13篇
  1994年   12篇
  1993年   8篇
  1992年   19篇
  1991年   18篇
  1990年   26篇
  1989年   23篇
  1988年   15篇
  1987年   11篇
  1986年   9篇
  1985年   10篇
  1984年   6篇
  1979年   5篇
  1975年   7篇
  1971年   8篇
  1970年   8篇
  1969年   5篇
  1968年   8篇
  1967年   6篇
  1966年   5篇
  1965年   5篇
排序方式: 共有5644条查询结果,搜索用时 15 毫秒
91.
Juvenile ossifying fibroma (JOF) is a rare fibro-osseous neoplasm, defined as a variant of the ossifying fibroma that arises within the craniofacial bones. Two subgroups, juvenile psammomatoid ossifying fibroma (PsJOF) and juvenile trabecular ossifying fibroma, have been delineated by their histology. PsJOF occurs predominantly in the sinonasal and orbital bones. This work reports on 2 cases of extensive PsJOF in the body of the right mandible as well as reviews the literature regarding the radiographic and histologic features, treatment, and prognosis of PsJOF of the jaws.  相似文献   
92.
Dengue fever has been a major problem in hospital settings in Brazil for the past 15 years. The main concern has been the severe forms, i.e., dengue hemorrhagic fever and dengue shock syndrome. Hemorrhagic events of different degrees have also been a major concern. We report five cases of large vein thrombotic events associated with the acute phase of dengue fever, including a previously non-reported case of mesenteric vein thrombosis. Complications such as these could have been overlooked in the diagnosis of dengue fever, given that the major concern is the hemorrhagic event.Dengue fever frequently affects Brazil, where thousands of cases have been diagnosed annually and all four dengue virus serotypes (DENV-1 through DENV-4) have been reported, sometimes concurrently in the same region.1,2 Hemorrhagic events of different degrees have often been described in dengue, but thrombotic events have not been extensively reported, despite the wide range of increased procoagulant activity during illness.1,38 During a recent outbreak, several cases of thrombotic events affected large veins in dengue fever patients. We report cases of unusual and overlooked complication of dengue fever.From January 2011 through March 2011 during a local outbreak of dengue fever caused by DENV-1 and DENV-2 according to local health officials, five patients were given diagnoses by imaging techniques (pulmonary computed tomography angiography, cholangio-magnetic resonance imaging, and Doppler ultrasound of lower extremities) as having large vessel thrombosis. These patients were part of 92 serologically confirmed (by immunochromatographic strip test or IgM antigen-capture enzyme-linked immunosorbent assay) patients with dengue (60% women and 40% men, median age = 39 years, age range = 10–99 years) admitted to Monte Sinai Hospital (200 beds) in Juiz de Fora, (population = 500,000), Minas Gerais, Brazil. This study was approved by the Ethical Committee of Monte Sinai Hospital.Twenty-three patients (25%) were classified as having dengue shock syndrome or dengue hemorrhagic fever and 4 deaths were recorded (case-fatality rate = 4.3%). These thrombotic patients represented 5.4% of all dengue inpatients. All thrombotic events were identified within the first five days of illness, and all patients had symptoms compatible with the reported thrombotic event at hospital admission. No thrombotic events were identified among the remaining patients during hospitalization, and none of the patients them received drugs for thrombosis prophylaxis, which is contraindicated in dengue.The demographic and clinical characteristics of the five patients are summarized in Figure 1), which was associated with jaundice and severe sepsis by Escherichia coli demonstrated by blood culture. Known risk factors for thrombotic events such as smoking, use of oral contraceptives, and being overweight were absent in all patients and none had had any similar diagnosis or symptoms.Open in a separate windowFigure 1.T1-weighted cholangio-magnetic resonance image with contrast of dengue patient 5 showing the superior mesenteric vein (SMV) with a large thrombus (arrow) occupying the vein lumen. SMA = superior mesenteric artery; IVC = inferior vena cava; Ao = aorta.

Table 1

Demographic, clinical, and laboratory characteristics of five dengue fever patients with thrombotic events, Brazil*
Patient/age (years)/sexPlatelets (× 109/L)Hematocrit, %Antibodies against phospholipid§ImagingManifestationsThrombotic eventIllness day of thrombosis diagnosis
1/89/F11333IgG 4.5, IgM 17.6Doppler USLeg pain and edemaDVT2
2/41/F11232.9IgG 7.9, IgM 1.9Doppler USLeg pain and edemaDVT3
3/89/F5245IgG 32.8, IgM 14.2CTADyspneaPTE1
4/51/F4541IgG 0.6, IgM 12.0CTADyspneaPTE2
5/61/M3742IgG 6.1, IgM 11.3C-MRISIRSMVT5
Open in a separate window*US = ultrasound; DVT = deep vein thrombosis; CTA = computed tomography angiography; PTE = pulmonary thromboembolism; C-MRI = cholangio-magnetic resonance imaging; SIRS = systemic inflammatory response syndrome; MVT = mesenteric vein thrombosis.Reference value = 140–400 × 109 /L (sample obtained on hospital day 1).Reference values: males = 41–53%; females = 36–46% (sample obtained on hospital day 1).§Reference value < 10 IgMPL/IgGPL (IgM phospholipid units, 1 IgMPL unit = 1 μg of IgM); IgGPL (IgG phospholipid units, 1 GPL unit = 1 μg of IgG).Increased levels of IgM against phospholipids were detected in four patients, but levels of IgG against phospholipids above the reference level were detected in only one patient (by enzyme immunoassay), and this was the only positive result in thrombophilia screening. Although most of the patients were dehydrated, severe hemoconcentration was not observed. Leukocyte counts were within the reference range and levels of D-dimer were increased in all patients. The international normalized ratio (prothrombin time) was normal or slightly prolonged in all patients and none had hemorrhagic events. None of the thrombotic patients were classified as having dengue shock syndrome or dengue hemorrhagic fever. All patients were treated with low molecular weight heparin and recovered. Although not completely understood, low platelet counts and function, increased vascular permeability, increased thrombomodulin, increased tissue plasminogen activator, and antibody cross-reactivity with endothelial cells and with specific coagulation proteins are among the suggested mechanisms responsible for hemorrhagic phenomena in dengue fever.38Myriad factors, including cytokines, fibrinolysis, and the complement system, might increase thrombotic risk in dengue fever patients.35 Increased PAI-1 plasma levels seem to be common in DENV infection and have been associated with greater risk for thrombosis.7 Disseminated intravascular coagulation and consequent microthombi formation have also been reported in dengue fever but have not been associated with large vessel thrombosis.5 Low concentrations of plasma anticoagulant proteins C and S and antithrombin III have also been detected in severe dengue but have not been associated with clinical thrombosis.4Increased levels of IgM against phospholipids were detected in all but one patient in this series, but these levels are of low clinical significance for thrombosis. Thus, except for increased levels of IgG against phospholipids in one patient, no other procoagulant risk factor was identified in this case series.9 Antibodies against phospholipids and increased lupus anticoagulant have been anecdotally associated with thrombotic events in peripheral arteries and cerebral vasculature in dengue fever patients.10,11 Venous cerebral vasculature thrombosis and ischemic stroke not associated with antibodies against phospholipids or other risk factors have been rarely reported in dengue fever patients.12Severe dehydration, a well known condition associated with thrombotic events, was not detected in any patient. All but one of the patients was > 50 years of age. Thus, the role of older age in thrombotic events in dengue fever should be considered. It is noteworthy that none of the thrombosis cases occurred in patients with dengue shock syndrome or dengue hemorrhagic fever, but the small number of patients with these conditions is not a reasonable explanation.The involved mechanism seems to be related to events that occurred during the early phase of the disease because the thrombotic events were clinically detected at admission and no episode of thrombosis was detected among the remaining dengue fever patients throughout hospitalization or during outpatient follow-up. Loss of endothelium non-thrombogenic protective factors has been identified in severe dengue early in the course of the disease.1To our knowledge, deep vein thrombosis, pulmonary thromboembolism, and mesenteric vein thrombosis have not been reported in direct association with dengue fever.1,11,12 Mesenteric vein thrombosis was an unusual complication of DENV infection, and was erroneously diagnosed in an imaging study of suspected cholangitis in a patient with clinical sepsis without a primary source. Awareness for these kinds of complications should be recommended to all practitioners who treat patients with dengue fever, particularly in hospital settings.  相似文献   
93.
94.
Brain abnormalities in Williams syndrome (WS) have been consistently reported, despite few studies have devoted attention to connectivity between different brain regions in WS. In this study, we evaluated corpus callosum (CC) morphometry: bending angle, length, thickness and curvature of CC using a new shape analysis method in a group of 17 individuals with WS matched with a typically developing group. We used this multimethod approach because we hypothesized that neurodevelopmental abnormalities might result in both volume changes and structure deformation. Overall, we found reduced absolute CC cross-sectional area and volume in WS (mean CC and subsections). In parallel, we observed group differences regarding CC shape and thickness. Specifically, CC of WS is morphologically different, characterized by a larger bending angle and being more curved in the posterior part. Moreover, although CC in WS is shorter, a larger relative thickness of CC was found in all callosal sections. Finally, groups differed regarding the association between CC measures, age, white matter volume and cognitive performance. In conclusions, abnormal patterns of CC morphology and shape may be implicated in WS cognitive and behavioural phenotype.  相似文献   
95.
The present Training Charter in Epilepsy Surgery Added Competence constitutes the third stage of a program initiated by the European Society for Stereotactic and Functional Neurosurgery (ESSFN) and substantiated in close collaboration with the Union Européennedes Médecins Spécialists (UEMS) and the European Association of Neurosurgical Societies (EANS). This program aims to raise the standards of clinical practice by guiding education and quality control concepts. The particular sections of this Charter include: definitions and standards of added competence training, relations of the Epilepsy Unit with the Neurosurgical Department, duration of epilepsy surgery fellowship, institution and training program director requirements, operative totals for epilepsy surgery, educational program, individual requirements, and evaluation and qualification of the trainees. The specification of all these requirements is expected to improve harmonisation and quality of epilepsy surgery practice across Europe, and enhance the clinical activity and the scientific productivity of existing neurosurgical centres.  相似文献   
96.
97.
98.
Methylglyoxal is a dicarbonyl compound that is physiologically produced by enzymatic and non-enzymatic reactions. It can lead to cytotoxicity, which is mainly related to Advanced Glycation End Products (AGEs) formation. Methylglyoxal and AGEs are involved in the pathogenesis of Neurodegenerative Diseases (ND) and, in these situations, can cause the impairment of energetic metabolism. Astroglial cells play critical roles in brain metabolism and the appropriate functioning of astrocytes is essential for the survival and function of neurons. However, there are only a few studies evaluating the effect of methylglyoxal on astroglial cells. The aim of this study was to evaluate the effect of methylglyoxal exposure, over short (1 and 3?h) and long term (24?h) periods, on glucose, glycine and lactate metabolism in C6 glioma cells, as well as investigate the glyoxalase system and AGEs formation. Glucose uptake and glucose oxidation to CO2 increased in 1?h and the conversion of glucose to lipids increased at 3?h. In addition, glycine oxidation to CO2 and conversion of glycine to lipids increased at 1?h, whereas the incorporation of glycine in proteins decreased at 1 and 3?h. Methylglyoxal decreased glyoxalase I and II activities and increased AGEs content within 24?h. Lactate oxidation and lactate levels were not modified by methylglyoxal exposure. These data provide evidence that methylglyoxal may impair glucose metabolism and can affect glyoxalase activity. In periods of increased methylglyoxal exposure, such alterations could be exacerbated, leading to further increases in intracellular methylglyoxal and AGEs, and therefore triggering and/or worsening ND.  相似文献   
99.
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号